Comparison of teicoplanin and vancomycin in initial empirical antibiotic regimen for febrile neutropenic patients

Trial Profile

Comparison of teicoplanin and vancomycin in initial empirical antibiotic regimen for febrile neutropenic patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 May 2009

At a glance

  • Drugs Teicoplanin; Vancomycin
  • Indications Febrile neutropenia; Gram-positive infections
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 18 May 2009 Primary endpoint 'Clinical response' has been met.
    • 18 May 2009 Results have been reported at 19th European Congress of Clinical Microbiology and Infectious Diseases.
    • 15 Sep 2008 sanofi-aventis reported as trial affiliate by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top